Schedule 13G ownership disclosure

Sagimet Biosciences Inc

Series A common stock · CUSIP: 786700104

Event date: 2025-06-24

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • AP11 Limited

    Shares: 1,504,642.00 · Class: 4.9%

  • Ascletis Pharma Inc.

    Shares: 1,504,642.00 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002069316-25-000001
Form type
SCHEDULE 13G/A
Filer
AP11 Ltd
CIK
CIK 2069316
Filed
Jun 24, 2025
Reporting period
Jun 24, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub